MSV
BMY icon

MN Services Vermogensbeheer’s Bristol-Myers Squibb BMY Stock Holding History

MN Services Vermogensbeheer’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.7M Sell
785,736
-6,000
-0.8% -$350K 0.31% 67
2025
Q4 		$42.7M Buy
791,736
+22,182
+3% +$1.07M 0.26% 83
2025
Q3 		$34.7M Buy
769,554
+8,900
+1% +$416K 0.22% 99
2025
Q2 		$35.2M Buy
760,654
+15,300
+2% +$751K 0.25% 89
2025
Q1 		$45.5M Sell
745,354
-58,400
-7% -$3.4M 0.35% 62
2024
Q4 		$45.5M Buy
803,754
+18,900
+2% +$1.06M 0.31% 63
2024
Q3 		$40.6M Sell
784,854
-19,400
-2% -$910K 0.28% 75
2024
Q2 		$33.4M Sell
804,254
-18,400
-2% -$823K 0.24% 89
2024
Q1 		$44.6M Sell
822,654
-175,400
-18% -$8.94M 0.32% 65
2023
Q4 		$51.2M Sell
998,054
-26,600
-3% -$1.4M 0.46% 57
2023
Q3 		$59.5M Buy
1,024,654
+16,400
+2% +$1M 0.57% 43
2023
Q2 		$64.5M Sell
1,008,254
-79,800
-7% -$5.35M 0.6% 38
2023
Q1 		$75.4M Buy
1,088,054
+39,900
+4% +$2.81M 0.78% 29
2022
Q4 		$75.4M Sell
1,048,154
-160,800
-13% -$12.1M 0.85% 26
2022
Q3 		$85.9M Sell
1,208,954
-79,600
-6% -$5.77M 0.91% 24
2022
Q2 		$99.2M Sell
1,288,554
-314,800
-20% -$24M 0.92% 25
2022
Q1 		$117M Sell
1,603,354
-106,600
-6% -$7.16M 0.78% 33
2021
Q4 		$107M Buy
1,709,954
+36,000
+2% +$2.11M 0.62% 41
2021
Q3 		$99M Buy
1,673,954
+30,900
+2% +$2.03M 0.61% 37
2021
Q2 		$92.6M Buy
+1,643,054
New +$107M 0.72% 33
2020
Q4 		$123M Buy
1,986,854
+24,400
+1% +$1.5M 0.87% 31
2020
Q3 		$118M Buy
1,962,454
+38,700
+2% +$2.33M 0.93% 26
2020
Q2 		$113M Sell
1,923,754
-71,700
-4% -$4.29M 0.97% 26
2020
Q1 		$111M Sell
1,995,454
-129,000
-6% -$7.88M 1.24% 17
2019
Q4 		$136M Buy
2,124,454
+683,662
+47% +$39.2M 1.16% 17
2019
Q3 		$73.1M Buy
1,440,792
+604,426
+72% +$28.4M 0.68% 39
2019
Q2 		$37.9M Sell
836,366
-65,200
-7% -$3.04M 0.45% 49
2019
Q1 		$43M Buy
901,566
+8,500
+1% +$423K 0.5% 47
2018
Q4 		$40.6M Buy
893,066
+630,792
+241% +$33.9M 0.62% 37
2018
Q3 		$16.3M Buy
262,274
+4,900
+2% +$291K 0.38% 54
2018
Q2 		$14.2M Hold
257,374
– – 0.36% 59
2018
Q1 		$16.3M Buy
257,374
+1,100
+0.4% +$70.8K 0.42% 48
2017
Q4 		$13.1M Sell
256,274
-15,400
-6% -$963K 0.41% 47
2017
Q3 		$17.3M Sell
271,674
-1,900
-0.7% -$111K 0.46% 44
2017
Q2 		$15.2M Buy
273,574
+229,004
+514% +$12.5M 0.42% 46
2017
Q1 		$2.27M Buy
44,570
+1,385
+3% +$76K 0.44% 42
2016
Q4 		$2.39M Hold
43,185
– – 0.49% 41
2016
Q3 		$2.33M Buy
43,185
+812
+2% +$52.2K 0.46% 45
2016
Q2 		$2.81M Buy
42,373
+557
+1% +$39.4K 0.65% 34
2016
Q1 		$2.34M Buy
+41,816
New +$2.64M 0.55% 38

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MN Services Vermogensbeheer's BMY Position: Q1 2026 in Review

MN Services Vermogensbeheer reduced its Bristol-Myers Squibb (BMY) stake by 0.76% in Q1 2026, selling an estimated $350K and leaving 785,736 shares worth $47.7M. The position accounts for 0.31% of the portfolio, ranked #67.

MN Services Vermogensbeheer first reported a position in BMY in Q1 2016 and has held it in 40 quarters since. The position peaked at $136M in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • MN Services Vermogensbeheer held 785,736 shares of Bristol-Myers Squibb worth $47.7M as of Q1 2026.
  • MN Services Vermogensbeheer sold 6,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $350K.
  • Bristol-Myers Squibb made up 0.31% of MN Services Vermogensbeheer's portfolio in Q1 2026, its #67 holding.
  • MN Services Vermogensbeheer first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 40 quarters since.
  • MN Services Vermogensbeheer's Bristol-Myers Squibb position peaked at $136M in Q4 2019.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.